Your browser doesn't support javascript.
loading
Safety, pharmacokinetics, and antitumor properties of anlotinib, an oral multi-target tyrosine kinase inhibitor, in patients with advanced refractory solid tumors.
Sun, Yongkun; Niu, Wei; Du, Feng; Du, Chunxia; Li, Shuting; Wang, Jinwan; Li, Li; Wang, Fengqing; Hao, Yu; Li, Chuan; Chi, Yihebali.
Afiliação
  • Sun Y; Department of Medical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences and PUMC, Beijing, 100021, China.
  • Niu W; The State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
  • Du F; The VIPII Gastrointestinal Cancer Division of Medical Department, Peking University Cancer Hospital and Institute, Beijing, 100142, China.
  • Du C; Department of Medical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences and PUMC, Beijing, 100021, China.
  • Li S; Department of Medical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences and PUMC, Beijing, 100021, China.
  • Wang J; Department of Medical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences and PUMC, Beijing, 100021, China.
  • Li L; The State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
  • Wang F; The State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
  • Hao Y; School of Public Health, Nanjing Medical University, Nanjing, China.
  • Li C; The State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China. chli@simm.ac.cn.
  • Chi Y; Department of Medical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences and PUMC, Beijing, 100021, China. dryihebalichi@126.com.
J Hematol Oncol ; 9(1): 105, 2016 10 04.
Article em En | MEDLINE | ID: mdl-27716285
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quinolinas / Terapia de Salvação / Inibidores de Proteínas Quinases / Indóis / Neoplasias Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Hematol Oncol Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2016 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quinolinas / Terapia de Salvação / Inibidores de Proteínas Quinases / Indóis / Neoplasias Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Hematol Oncol Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2016 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido